Items where authors include "Burgess, M"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 7.

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Brown, E, Wilton, MM, Sprung, VS et al. (9 more authors) (2021) A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol. BMJ Open, 11 (7). e045663. ISSN 2044-6055

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Schmid, P, Abraham, J, Chan, S et al. (26 more authors) (2020) Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial. Journal of Clinical Oncology, 38 (5). pp. 423-433. ISSN 0732-183X

Gao, J, Tian, G, Jenner, P et al. (2 more authors) (2020) Preliminary explorations of the performance of a novel small scale opposed rotary piston engine. Energy, 190. 116402. p. 116402. ISSN 0360-5442

Bissell, L-A orcid.org/0000-0002-2789-4652, Anderson, M, Burgess, M et al. (10 more authors) (2017) Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis. Rheumatology, 56 (6). pp. 912-921. ISSN 1462-0324

This list was generated on Sat May 4 09:20:45 2024 BST.